Bijan Forough, MD

Role in study: Co-author, Study 12 -- "Continuous Shortwave Diathermy with Exercise Reduces Pain and Improves Function in Lateral Epicondylitis More Than Sham Diathermy: A Randomized Controlled Trial" (Journal of Bodywork & Movement Therapies, 2020; PMID 31987565)

Verification date: 2026-09-18

Career

Dr. Forough has built his career at the Neuromusculoskeletal Research Center of Iran University of Medical Sciences (Firoozgar Hospital), Tehran, from 2008 to the present.
His training includes a medical education at IUMS Firouzgar Hospital (1992-1995).
PubMed indexes his career under two surname spellings, Forough (including Study 12) and Forogh (69 records) -- one distinguished physician-researcher, unified by the same personal e-mail across both spellings and the identical institution line.

Research Work

Dr. Forough's research spans lateral epicondylitis orthoses, TMS/tDCS, acupuncture randomized trials, ozone injections, dry needling, PRP, gait and balance, and the history of physical medicine and rehabilitation in Iran: 73 PubMed records, 2008-2026, across both surname spellings.
His ORCID record carries 54 works with 15 or more verbatim matches to his corpus, including carpal tunnel prolotherapy (2022), quadriceps dry needling (2023), rTMS versus tDCS (2021), and extracorporeal shockwave therapy (2021).
He is co-author of Study 12, a randomized placebo-controlled trial in which adding continuous shortwave diathermy to a specific exercise regimen reduced pain and improved function in chronic lateral epicondylitis more than sham diathermy and exercise (50 patients, intention-to-treat analysis, outcomes at baseline, sessions 5 and 10, and 3 months).

Role in Study 12

Co-author of Study 12. See Study 12: Shortwave Diathermy Enhances Recovery in Lateral Epicondylitis (Journal of Bodywork & Movement Therapies, 2020; PMID 31987565).

Identifiers

ORCID: 0000-0002-3718-8719

Relationship statement: King Brand utilized the individual's work in the development of our products and treatments. The study and all the professional's work was independent of King Brand - they did not work for us, nor were they compensated by us - it is truly independent. King Brand has relied on the results of this study, this individual's work, and the work and studies of others in the development of our medical solutions.

Sources

ORCID public record 0000-0002-3718-8719 · PubMed class, dominant spelling (Forogh B) · PubMed class, study spelling (Forough B) · Study 12 on PubMed (PMID 31987565)

Profile verified as of 2026-09-18; annual re-verification scheduled.

← All honored medical professionals and researchers · Study 12 →